Since the introduction of streptomycin, though some of the vaunted indications have suffered set-back, new indications for its use have also been brought to light, which have added to the therapeutic glory of the drug. Streptomycin was ushered in as a drug specific for tuberculosis. Gradually it became clear that though it is comparatively a potent drug against the infection, it could not be claimed as a cure in a majority of the cases. Its efficacy was observed in a limited degree in meningeal and miliary tuberculosis and in fibro-caseous type of pulmonary tuberculosis only in conjunction with the collapse therapy.
With more extensive use of streptomycin its toxicity and capacity to produce resistant strains of tubercle bacilli were brought to light, which diminished its usefulness to some extent. At the same time it was realized that the drug had a benign influence over a number of conditions other than tuberculosis. Thus the spectrum of its indications widened in spite of its manifest drawbacks. It proved to be of great help in the treatment of non-tuberculous conditions like urinary infections, lymphogranuloma inguinale, some lung infections, cirrhosis of the liver, gastro-enteritis, etc.
The dosage of streptomycin has also undergone a great change. In the early part of its discovery, maintenance of the optimum concentrations of the drug in the blood was considered incumbent. At that time the author had stressed the essential difference (Mattei, 1951 (Marshall, 1951) Clinical experience has shown that many infections can be adequately controlled by intermittent treatment, with long penicillin-free intervals (Editorial, 1951) . Clinical experience with intermittent treatment by streptomycin has also been reported to be satisfactory (James et al., 1951; Bingall et al., 1950 (Bingall et al., 1950; James et al., 1951 
